pharmaceut top-read note februari
focu large-cap pharma includ abbv/mrk also set-up
includ link top-read notes/report publish februari proxi
see greatest investor interest top note rank order
most-read case sinc earli januari large-cap pharma drove readership
follow abbv strong guidanc mrk decis spin women
legaci brand biosimilar busi reflect most-read incom call volum
remain notabl high among specialti pharma coverag drove
focu recent report earn see stock pull-back beyond relat
notes/report publish februari top rank order most-read
activ link remaind page
rais number solid execut set-up close favor feb
debat introduc easi stock maintain sp lower price target
teva bull/bear debat clear hing upon abil grow ebitda three takeaway feb
continu see favor set-up competit survey result encourag feb
industri pharmaceut new cgrp survey deep dive feb
industri pharmaceut focus next week dinner heavi earn week
four primari takeaway manag meet expect momentum
agn strong result provid encourag read-through abbv/agn pro-forma outlook feb
industri specialti pharma case sector consolid feb
teva focus call sever move part around set-up feb
industri pharmaceut focus next week teva result agrx
pdufa india earn feb
 result larg line focu announc legaci asset spin feb
agrx twirla approv mileston women health reiter o-spec rate rais pt feb
anoth invest year xyrem debat continu strateg debat pick feb
price prior trade day market close estimate unless otherwis note
valu usd unless otherwis note
pharmaceut top-read note februari
note publish februari order most-read
industri pharmaceut focus next week agrx pdufa
januari symphoni data cgrp opioid feb
learn today sell side lunch feb
industri pharmaceut focus next week
newco spin focu women health introduc new consolid
posit agrx feb
industri gener pharma earn read cipla zydu lupin sun feb
report larg in-lin quarter modest upsid expect
focu remain pend deal close feb
compel small cap opportun think miss feb
thought set-up ahead continu see improv risk/reward
pro-forma forecast larg unchang continu see
drive strength thought current
industri pharmaceut top-read note januari focu large-cap pharma
teva teva gener solid ebitda guid line sever
steadi perform focu shift swing factor price target
feb
first-tim guidanc underwhelm stock perform come
solid achiev set-up focu pivot oper leverag reiter op
encourag read-through execut key read teva
lesser degre feb
report posit interim analysi metastat tnbc
support use earli tnbc feb
pharmaceut top-read note februari
uncertainti remain high follow miss on-going sale process feb
look construct margin pressur new question lower ep
target feb
downward trend closer look teva feb
continu see meaning inflect thought post
anticip competitor cgrp market read agn/abbv teva see deep dive
delay posit reason pdufa extens unclear add
support ahead first time guid tomorrow feb
januari symphoni data modestli impli consensu forecast
focu shift first-tim guidanc thur feb
report solid beat initi guidanc bar straddl
consensu encourag start year feb
viatri cfo board appoint complet like
feb
report beat buoy later year complex gener launch
guidanc come move part drive focu feb
revenu consist pre-announc ep guid
street sever question call feb
pharmaceut top-read note februari
analyst respons prepar research report receiv compens base upon variou factor includ
total revenu member compani capit market affili portion gener
invest bank activ member compani capit market affili
pleas note current conflict disclosur may differ public date set forth
report access current conflict disclosur client refer http //www rbccm com/gldisclosure/publicweb/
send request cm research publish bay street royal bank plaza
member compani capit market one affili manag co-manag public offer secur
abbvi inc past month
member compani capit market one affili receiv compens invest bank servic
abbvi inc past month
capit market llc make market secur abbvi inc
member compani capit market one affili receiv compens product servic
invest bank servic abbvi inc past month time member compani capit
market one affili provid non-secur servic abbvi inc
capit market current provid abbvi inc non-secur servic
capit market provid abbvi inc invest bank servic past month
capit market llc make market secur merck co inc
member compani capit market one affili receiv compens product servic
invest bank servic merck co inc past month time member compani capit
market one affili provid non-invest bank securities-rel servic merck co inc
capit market current provid merck co inc non-invest bank securities-rel servic
capit market provid merck co inc non-invest bank securities-rel servic past month
capit market llc make market secur
capit market llc make market secur inc
capit market llc make market secur perrigo compani public limit compani
explan capit market equiti rate system
analyst sector univers compani analyst provid research coverag accordingli rate assign
particular stock repres sole analyst view stock perform next month rel
analyst sector averag although capit market rate top pick tp /outperform sector perform sp
under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
top pick tp repres analyst best idea sector expect provid signific absolut total return month
favor risk-reward ratio
outperform expect materi outperform sector averag month
sector perform sp return expect line sector averag month
pharmaceut top-read note februari
under-perform return expect materi sector averag month
restrict polici preclud certain type commun includ invest recommend
act advisor certain merger strateg transact certain circumst
rate nr rate price target estim remov due applic legal regulatori polici constraint
may includ capit market act advisori capac involv compani
specul risk rate reflect secur lower level financi oper predict illiquid share trade volum
high balanc sheet leverag limit oper histori result higher expect financi and/or stock price volatil
distribut rate
purpos rate distribut regulatori rule requir member firm assign rate one three rate categori
 buy hold/neutr sell regardless firm rate categori although capit market rate top pick/
outperform sector perform under-perform close correspond buy hold/neutr sell respect mean
rate determin rel basi
distribut rate
rate price target histori abbvi inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
pharmaceut top-read note februari
rate price target histori merck co inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
rate price target histori mylan us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
pharmaceut top-read note februari
rate price target histori inc us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
rate price target histori perrigo compani public limit compani us usd
tp top pick outperform sp sector perform under-perform restrict initi research coverag discontinu research coverag
nr rate na avail rl recommend list rl refer date secur place recommend list rl refer date
secur remov recommend list rtg rate
creat bluematrix
refer recommend list recommend histori chart may includ one recommend list model
portfolio maintain wealth manag one affili wealth manag recommend list includ
guid portfolio prime incom rl guid portfolio dividend growth rl guid portfolio adr rl
guid portfolio cap growth rl capit market recommend list includ strategi focu list
fundament equiti weight portfolio abbrevi rl mean date secur place
recommend list abbrevi rl mean date secur remov recommend list
equiti valuat risk
valuat method use determin risk may imped achiev price target cover compani pleas
see recent company-specif research report http //www rbcinsightresearch com send request capit
pharmaceut top-read note februari
price target base equal ev/ebitda price-to-earnings estim reflect close allergan
acquisit use multipl respect reflect meaning discount histor industri averag
adjust us loss exclus humira impli return price target support sector perform rate
risk rate price target
risk rate price target includ limit tail valu risk humira still meaning contributor
combin compani acquisit risk work close integr allergan transact largest deal
histori regulatory/polit risk broadli applic sector particularli around pricing/reimburs
price target base equal price-to-earnings ev/ebitda remainco estim use multipl
respect get us per share ad per share contribut newco spin close
multipl use reflect price target framework appli premium histor industri averag
give compani credit high-growth profil off-set portfolio concentr impli return
price target support sector perform rate
risk rate price target
risk rate price target includ limit tail valu risk loss exclus loe concern
januvia primarili keytruda busi develop risk compani continu activ
posit long-term growth portfolio diversif outsid keytruda focus smaller/earlier-stag asset
inher riski pipelin risk work develop acquir intern develop asset pricing/
polit risk broadli applic sector particularli around pricing/reimburs
price target base equal price-to-earnings ev/ebitda multipl appli newco estim use target
multipl respect result gener price target framework taken trough
price-to-earnings valuat histor averag ev/ebitda valuat made adjust base company-specif attribut
ev/ebitda incorpor opioid liabil within capit structur price target modestli valuat level
trade pre-deal announc sector histor averag multipl reflect continu
challeng industri impli return price target opportun upsid support outperform rate
risk rate price target
risk rate price target includ limit delay around pipelin convers slower expect
new launch uptak impair us base busi delay upjohn deal close and/or integr issu
inopportun use cash boost leverag and/or impair sharehold valu
price target base equal discount cash flow dcf analysi discount price-to-earnings dcf yield per share
reflect explicit forecast wacc termin growth rate beyond price-to-earnings get us per
share ep impli return price target support outperform rate
risk rate price target
pharmaceut top-read note februari
potenti downsid risk price target rate aris price risk key concern may
imped adopt greater util product regulatory/bundl risk bundl payment orthoped
procedur competit risk data risk ph iv read-out pipelin product develop
price target base blend price-to-earnings ev/ebitda multipl use cy estim assum multipl
respect taken histor averag global consum multipl price-to-earnings ev/ebitda
made adjust base company-specif attribut private-label discount earn momentum gener busi discount
litig risk collect result valuat discount impli return price target support sector
risk rate price target
organ revenu growth consum self-car america segment soften due weaker-than-expect over-the-counter market
growth greater-than-expect price eros
delay fda approv gener drug applic result declin revenu and/or margin rx segment
unexpect meaning competit entri us store brand over-the-counter rx busi
capit market polici manag conflict interest relat invest research avail us request
access current polici client refer
send request capit market research publish bay street royal bank plaza floor south
tower toronto ontario reserv right amend supplement polici time
dissemin research short-term trade idea
capit market endeavor make reason effort provid research simultan elig client
regard local time zone oversea jurisdict capit market equiti research post proprietari websit
ensur elig client receiv coverag initi chang rate target opinion time manner addit
distribut may done sale personnel via email fax electron mean regular mail client may also
receiv research via third parti vendor capit market also provid elig client access sparc firm
proprietari insight websit via email via third-parti vendor sparc contain market color commentari regard
subject compani firm current provid equiti research coverag research analyst may time time
includ short-term trade idea research report sparc short-term trade idea offer short-term view
secur may trade base market trade event result trade opportun may avail
short-term trade idea may differ price target recommend publish research report reflect
research analyst view long-term one year prospect subject compani result differ time horizon
methodolog and/or factor thu possibl subject compani common equiti consid long-term
sector perform even under-perform might present short-term buy opportun result temporari sell pressur
market convers subject compani common equiti rate long-term outperform could consid suscept
short-term downward price correct short-term trade idea rate part rate system
firm gener intend undertak oblig maintain updat short-term trade idea short-term trade
idea may suitabl investor tailor individu investor circumst object
investor make independ decis regard secur strategi discuss herein pleas contact
invest advisor institut salesperson inform regard capit market research
list recommend compani dissemin prior period pleas click
month histori sparc view http //www rbcinsightresearch com
pharmaceut top-read note februari
view express report accur reflect person view respons analyst
subject secur issuer part compens respons analyst name herein directli
indirectli relat specif recommend view express respons analyst report
global industri classif standard gic develop exclus properti servic mark inc standard poor financi servic
llc licens use neither parti involv make compil gic gic classif make express impli
warranti represent respect standard classif result obtain use thereof parti herebi expressli disclaim warranti
origin accuraci complet merchant fit particular purpos respect standard classif without limit forego
event shall affili third parti involv make compil gic gic classif liabil direct indirect special
punit consequenti damag includ lost profit even notifi possibl damag
refer herein libor libo rate libor abbrevi mean london interbank offer rate administ benchmark administr
person take administr rate
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict capit
market may restrict publish research report time time due regulatori restrict and/ intern complianc polici case
latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject compani
capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri busi
secur broker dealer jurisdict full extent permit law neither capit market affili person accept
liabil whatsoev direct indirect consequenti loss aris connect use report inform contain herein
matter contain document may reproduc copi mean without prior written consent capit market instanc
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
